Chinese mobile health app, Xingren Doctor, announced Wednesday that it has raised 200 million RMB (roughly $32 million USD) in series B financing led by FountainVest Partners, followed by current investors Sequoia Capital China and LightSpeed China Partners.

The investment will go primarily into product development and improving their overall business model, said Martin Shen, founder and CEO of the company.

Xingren Doctor is an mobile healthcare app targeted at doctors, helping them to better manage patients, workplace communications and industry updates. Available for both iOS and Android, doctors in China are using this app to communicate and track the status of their patients, contact other doctors on the network, or follow trends within their specialties.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Emma Lee

Emma Lee is Shanghai-based tech writer, covering startups and tech happenings in China and Asia in general. We are looking for stories related to tech and China. Reach her at lixin@technode.com.